These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31523049)

  • 1. Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.
    Sepriano A; Ramiro S; FitzGerald O; Østergaard M; Homik J; van der Heijde D; Elkayam O; Thorne JC; Larché MJ; Ferraccioli G; Backhaus M; Burmester GR; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel A; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Paschke J; Dadashova R; Hutchings E; Landewé R; Maksymowych WP
    J Rheumatol; 2020 Jun; 47(6):809-819. PubMed ID: 31523049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
    Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
    Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA.
    Maksymowych WP; FitzGerald O; Østergaard M; Homik J; van der Heijde D; Lambert RG; Elkayam O; Ramiro S; Thorne JC; Larché MJ; Ferraccioli G; Backhaus M; Burmester GR; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel A; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Paschke J; Dadashova R; Hutchings E; Sepriano A; Landewé R
    J Rheumatol; 2020 Jun; 47(6):796-808. PubMed ID: 31474600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM.
    Ramiro S; Landewé R; van der Heijde D; Sepriano A; FitzGerald O; Østergaard M; Homik J; Elkayam O; Thorne JC; Larché MJ; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
    Rheumatology (Oxford); 2023 Sep; 62(9):2989-2997. PubMed ID: 36645243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
    Sepriano A; Ramiro S; Landewé R; van der Heijde D; Ohrndorf S; FitzGerald O; Backhaus M; Larché M; Homik J; Saraux A; Hammer HB; Terslev L; Østergaard M; Burmester G; Combe B; Dougados M; Hitchon C; Boire G; Lambert RG; Dadashova R; Paschke J; Hutchings EJ; Maksymowych WP
    Clin Rheumatol; 2024 Jun; 43(6):1833-1844. PubMed ID: 38684600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea.
    Song JJ; Song YW; Bae SC; Cha HS; Choe JY; Choi SJ; Kim HA; Kim J; Kim SS; Lee CK; Lee J; Lee SH; Lee SS; Lee SK; Lee SW; Park SH; Park W; Shim SC; Suh CH; Yoo B; Yoo DH; Yoo WH
    J Korean Med Sci; 2018 Dec; 33(52):e346. PubMed ID: 30584418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.
    Vermeer M; Kuper HH; Bernelot Moens HJ; Hoekstra M; Posthumus MD; van Riel PL; van de Laar MA
    Arthritis Res Ther; 2012 Nov; 14(6):R254. PubMed ID: 23176083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
    Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.
    Wabe NT; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee AT; Spargo LD; Metcalf RG; Hall C; Proudman SM; Wiese MD
    J Rheumatol; 2016 Sep; 43(9):1643-9. PubMed ID: 27422892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient-centered knowledge translation tool for treat-to-target strategy in rheumatoid arthritis: Patient and rheumatologist perspectives.
    Benham H; Chiu H; Tesiram J; Mehdi A; Landsberg P; Grosman S; Harrison A; Nash P; Thomas R; Langbecker D; Van Driel M
    Int J Rheum Dis; 2021 Mar; 24(3):355-363. PubMed ID: 33470051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.
    Markusse IM; Dirven L; Han KH; Ronday HK; de Sonnaville PB; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):446-53. PubMed ID: 26239288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
    Xie W; Li J; Zhang X; Li G; Hao Y; Zhao J; Wang L; Sun X; Fan Y; Zhang Z
    Clin Exp Rheumatol; 2018; 36(5):820-828. PubMed ID: 29533754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
    Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
    Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
    Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis.
    Hao Y; Oon S; Nikpour M
    Semin Arthritis Rheum; 2024 Aug; 67():152465. PubMed ID: 38796922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf RG; Hall C; Proudman SM; Wiese MD
    Arthritis Res Ther; 2015 Mar; 17(1):48. PubMed ID: 25889527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study.
    Sugihara T; Ishizaki T; Onoguchi W; Baba H; Matsumoto T; Iga S; Kubo K; Kamiya M; Hirano F; Hosoya T; Miyasaka N; Harigai M
    Rheumatology (Oxford); 2021 Sep; 60(9):4252-4261. PubMed ID: 33410490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.
    Brinkmann GH; Norvang V; Norli ES; Grøvle L; Haugen AJ; Lexberg ÅS; Rødevand E; Bakland G; Nygaard H; Krøll F; Widding-Hansen IJ; Bjørneboe O; Thunem C; Kvien T; Mjaavatten MD; Lie E
    Semin Arthritis Rheum; 2019 Apr; 48(5):808-814. PubMed ID: 30205983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.